相关实验视频

Updated: Jan 18, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

13.1K

验证和使用心脏NAM用于毒性查和药物开发

Jennifer Beck Pierson1, Anthony Bahinski2, Brian Berridge3

  • 1Health and Environmental Sciences Institute, Washington, DC, USA.

International journal of toxicology
|September 9, 2025
PubMed
概括

新的人类相关模型,包括干细胞衍生的心肌细胞和人工心脏组织,正在改善早期药物安全性评估. 在药物开发中,合作是验证和采用这些道德,高效的新方法方法 (NAM) 的关键.

关键词:
这是心脏病,心脏病.心血管疾病的心血管疾病药物安全 药物安全新方法方法论新方法方法论毒理学 毒理学 毒理学

更多相关视频

Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening10:39

Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening

Published on: April 15, 2017

13.5K
Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes10:30

Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Published on: August 4, 2022

3.4K

相关概念视频

Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
181